Company Special: Techpool transforms into international player

Techpool Bio-Pharma Co has experienced tremendous changes in the past three year under the leadership of its new chief executive officer, transforming from a traditional private Chinese company to an international player.

Before Henry Lee took office in 2011, he was the senior executive in many leading companies in the pharmaceutical field, including Novartis and Eisai, with more than 20 years successful management experience in both China and the Asia-Pacific region.

"I chose Techpool because of its huge development potential. Also, it had a pure, positive and healthy corporate culture, which was different from what I imagined, as I thought most Chinese private companies have complex and chaotic personal relations," Lee said.